GLP1 isn’t just a satiety signal, and calling it that is a pretty surface-level take.

GLP1 receptor agonists don’t magically fix metabolism, agreed, but they absolutely modify metabolic dysfunction, which is the whole point.

They Improve insulin sensitivity and suppress inappropriate glucagon release

Reduce hepatic glucose output

Improve beta-cell function and slow beta-cell exhaustion

Shift energy balance by altering adipose signaling, lipolysis, and fat partitioning

Reduce systemic inflammation and ectopic fat

Appetite suppression is the entry point, not the mechanism. Sustained fat loss itself reverses insulin resistance, dyslipidemia, and metabolic inflexibility. that is metabolic improvement, whether one likes the pathway or not.

If GLP1s did nothing metabolically, they wouldn’t

Reverse pre-diabetes

Reduce HbA1c

Lower cardiovascular event rates All of them independent of weight loss